1. Home
  2. FIG vs DXCM Comparison

FIG vs DXCM Comparison

Compare FIG & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FIG

Figma Inc.

N/A

Current Price

$36.11

Market Cap

24.9B

Sector

Technology

ML Signal

N/A

Logo DexCom Inc.

DXCM

DexCom Inc.

HOLD

Current Price

$66.84

Market Cap

25.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIG
DXCM
Founded
2012
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.9B
25.9B
IPO Year
2025
2005

Fundamental Metrics

Financial Performance
Metric
FIG
DXCM
Price
$36.11
$66.84
Analyst Decision
Hold
Strong Buy
Analyst Count
10
21
Target Price
$67.63
$87.90
AVG Volume (30 Days)
6.3M
5.3M
Earning Date
11-05-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.75
EPS
N/A
1.80
Revenue
$968,957,000.00
$4,515,900,000.00
Revenue This Year
$40.85
$17.41
Revenue Next Year
$23.13
$12.78
P/E Ratio
N/A
$37.27
Revenue Growth
91.92
14.21
52 Week Low
$32.83
$54.11
52 Week High
$142.92
$93.25

Technical Indicators

Market Signals
Indicator
FIG
DXCM
Relative Strength Index (RSI) N/A 60.62
Support Level N/A $64.00
Resistance Level N/A $69.77
Average True Range (ATR) 0.00 1.96
MACD 0.00 0.78
Stochastic Oscillator 0.00 72.06

Price Performance

Historical Comparison
FIG
DXCM

About FIG Figma Inc.

Figma Inc is engaged in transforming ideas into digital products and experiences. The group focuses on the entire software creation lifecycle, enabling it to quickly launch new products on Figma's browser-based platform and reinforcing its belief that design extends well beyond a single step or role. The company adopts an expansive view, as design is more than how something looks, feels, or works. It derives its revenue from sales of subscriptions for access to its platform.

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Share on Social Networks: